HBV-DNA and infected hepatocytes dynamics in HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), lamivudine, or PEGASYS (R) plus lamivudine combination therapy using a new bio-mathematical model